% | $
Quotes you view appear here for quick access.

Cytosorbents Corporation Message Board

betasplen1 179 posts  |  Last Activity: May 29, 2015 1:56 PM Member since: Mar 2, 2004
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    VVUS projected to make .66 cents a share!!!!

    by bubbleboy2225 May 28, 2015 9:18 AM
    betasplen1 betasplen1 May 29, 2015 1:56 PM Flag

    So Rup. I need an example of a BK pharma that had analysts promising the sky on Yahoo! Finance and also how VVUS will go bankrupt given the current and future financials. After giving bubbles a hard time on not providing proof to back up his statement, you can't do the same, can you? Bubbles did his part. Your turn now. I am waiting...

  • Reply to

    Qsymia and the Silent Partner - Fact or Theory?

    by michael778150 May 29, 2015 10:30 AM
    betasplen1 betasplen1 May 29, 2015 12:08 PM Flag

    Geez Mike, do you work for the FBI? That's a lot of gray matter exercised for a stock that has become an immovable object in the mid $2s. You sure come up with a lot of positive conspiracy theories. Good reading material. Keep it up!

  • Reply to

    VVUS projected to make .66 cents a share!!!!

    by bubbleboy2225 May 28, 2015 9:18 AM
    betasplen1 betasplen1 May 28, 2015 2:31 PM Flag

    OK Rup, it's your turn now. Show me one of those bankrupt pharmas where you can pull up analyst's consensus promising the sky? Speaking of bankruptcy, tell us how a company that has $56MM in net cash (after subtracting debt) and $300MM in royalties and milestones in the future, can declare bankruptcy? Oh and let's forget that Q could become the best selling weight loss drug after ARNA/OREX issues and that Stendra/Spedra could take off with ENDO doubling it's marketing efforts and EU countries warming up to the 15 min onset. Explain your bankruptcy theory to us. I'd like to hear it since there is not much else to discuss while we wait for improving sales and earnings...

  • Reply to

    Which analyst

    by betasplen1 May 27, 2015 5:06 PM
    betasplen1 betasplen1 May 28, 2015 11:17 AM Flag

    I'll take 38 cents for the entire year if they can achieve it. I sure hope that all this waiting will work out in the end. This is the longest I have so much money tied up in one stock. Not a good investment plan by any means but I can't see why this won't rebound since all facts point to a $12 stock in a year (at least)....

  • betasplen1 by betasplen1 May 27, 2015 5:06 PM Flag

    actually sees the improving metrics behind the doom and gloom that the stock is displaying? One of the 6 analysts covering the company has $0.38 in earnings and $222MM in revenues for 2016. All the facts we know today are supporting that analyst who seems to be actually doing his homework. Does anyone know who that is?
    A conservative PE of 30 and PS of 5 will put the stock in the $11-12 range without any short squeeze required. Of course, a share buyback will get us there much sooner and a windfall for a management (and the company) that has the smarts to pull it off. But Seth and co. do not fit that category in any way. However, if they can meet those estimates, because their products work and not necessarily because of their smarts, I will still forgive them for the total lack of fiduciary duty for the past year (and counting). Till then, I will call a spade a spade. Lazy ignoramuses....

  • betasplen1 betasplen1 May 26, 2015 10:45 AM Flag

    They are morons, sloths, pricks and ignoramuses. I don't use expletives and so that will cover most of it. They are quick to file a 8K but won't tell us or do anything that will actually help the stock price.

  • Reply to

    This sucks

    by betasplen1 May 22, 2015 10:08 AM
    betasplen1 betasplen1 May 22, 2015 6:13 PM Flag

    Thanks for your advice and sympathy (Rup). I do have a longer horizon than when I was with Horizon Pharma, pun intended. Maybe 2-3 years. It's just that I don't think the execs care a hoot about shareholders. They have never lamented that the stock is trading below cash value for over 200 days or that they feel that the company is drastically undervalued. They go about doing their thing as though they have all the time in the world to meet their business objectives. It looks like they want the company to survive long term so that they will keep getting their salaries, not to do what a CEO of any other publicly traded company needs to do to keep his job - to increase shareholder value. There seems to be no sense of urgency and they do not respond to analysts or shareholders who are #$%$ off with the stock performance. Maybe their business strategy will eventually take care of the stock price but that's just a guess at this time. When there are sure shot ways to help the shareholders, they don't throw a single lousy bone! That's what #$%$ me off with Seth and co.

  • betasplen1 by betasplen1 May 22, 2015 10:08 AM Flag

    and I am tempted to sell so that VVUS can track HZNP from the $2s to $30. The latter sat in the $2s for a year as well with an inexplicably large short position and I sold in disgust. Maybe that's what it takes (my share sell back) since the morons will not do a share buyback...

  • betasplen1 betasplen1 May 21, 2015 10:37 AM Flag

    bubble, I for one, am one of those who says they have done nothing for shareholders. I do like the way they are going about tackling the business strategy. But the stock has fallen 90% since Seth took over and is a dream stock for shorts ever since. He should have noticed that improving fundamentals, new patents and higher revenues have done NOTHING, NADA, ZILCH to move the needle on the stock price or short position. So, if he has any common sense, he should either be buying a ton of shares in the open market or using some of the company funds (or borrow more money at low interest rates if risk averse) to institute a company share buyback. This will get the shorts scattering, the analysts re-thinking their recommendations, potential acquirers putting together a proposal faster, providing a great avenue to raise funds for the company by re-selling those shares at much higher prices and last but not least, be shareholder friendly!!

  • Reply to


    by howie_feltersnatch_22 May 21, 2015 9:37 AM
    betasplen1 betasplen1 May 21, 2015 10:12 AM Flag

    Time to kick Seth out next! And bring in a CEO who cares a hoot about shareholders. I have sent 15 emails over the past 2 months and not even an acknowledgement. I can imagine him showing me the finger as he does to some of the analysts on the earnings call. The guy does not know the difference between running a public and private enterprise. Such incompetence should be rewarded with a pink slip...

  • Reply to


    by suadela24 May 19, 2015 4:12 PM
    betasplen1 betasplen1 May 19, 2015 5:37 PM Flag

    You meant for the day, correct? I am still down 20% on this sorry excuse of a stock. Management is sleeping with the shorts - what morons!

  • Reply to


    by pr5250 May 6, 2015 10:04 AM
    betasplen1 betasplen1 May 19, 2015 7:34 AM Flag

    pr5250, your thoughts are similar to mine and pmt's (excluding the Stendra is a wash statement). That's why I have been begging the company to change status quo with the shorts. Improving financials or increasing institutional support does not seem to make a dent in the short and mid term. They have to couple it with a share buyback announcement (or insider buying in the open market as a second choice). Only then will there be belief in the street that these clowns actually have a plan to deliver for their shareholders.

  • betasplen1 betasplen1 May 18, 2015 10:09 AM Flag

    I second that. So, we now have competitors (OREX, ARNA) running into potential issues with partnerships and inefficacy respectively. We have Teva and Actavis potentially mulling a bid for Q (or VVUS itself) with their otherwise meaningless ANDA submissions. We see Q scripts approaching new all-time highs, We see Stendra marketing efforts ramped up by ENDO this month after a temporary hiccup with their M&A activity. We see the potential for CVOT to be modified to VVUS's favor, thereby reducing cash burn in the future and EU approval. Stock is still in the gutter. But what is new? All I can say is we can sleep well at night knowing that it is ridiculously undervalued, given the facts, unless you need the money today.

  • betasplen1 betasplen1 May 15, 2015 12:52 PM Flag

    Hey rup, you know that this poster is not your venerable doc, no? Not that I read any of your idol's posts (was before my time) but this ID was created recently. Must be a parody of his Belviq/ARNA addiction. If he really is your Dr. Henry, I am not at all impressed. Sounds like a typical pumper on the wrong board...

  • Reply to

    Real World Efficacy

    by stockotter May 11, 2015 7:06 AM
    betasplen1 betasplen1 May 14, 2015 2:42 PM Flag

    Thanks for sharing your personal experience with Q. This is what we need here - testimonials from real users. Of course, we cannot validate the veracity of these anecdotes but it is far better than the boring reflections on daily stock price movements and constant ridiculing of each other. I like the news lately but ain't getting excited till we cross $4 (not $3). Who knows when?? In the mean time, where is the freakin' share buyback or insider buying? I have sent the morons a dozen emails and not even an acknowledgement of receipt. Punks....

    PS: I met Seth while in the rainforest the past couple of weeks, hanging off a high branch..not a care in the world about anything really. The ticos called him "sloth" for some reason...

  • Reply to

    VVUS Price Target raised to $13, Wow

    by rbakboy May 13, 2015 2:15 PM
    betasplen1 betasplen1 May 14, 2015 10:02 AM Flag

    Where do you see this or is this just another prediction? All I see is a JP Morgan upgrade to $13 in 2010...

  • betasplen1 by betasplen1 Apr 28, 2015 9:38 PM Flag

    No share buyback, no price recovery. They can keep announcing positive developments till the cows come home. Shorts will simply make a mockery of it each time. Why? Because they can. Start bombarding management for it or keep watching this inexplicable collapse...

  • Reply to

    news....corporate update

    by ososilver1 Apr 27, 2015 9:08 AM
    betasplen1 betasplen1 Apr 27, 2015 10:30 AM Flag

    2 months to potential blast off. There is still a lot of pessimism (or just plain ignorance) on whether they will file the BLA this quarter, as can be seen from the current price and low volume. But it sure looks like a slam dunk for 2016 commercial availability from all known facts to date...

  • betasplen1 betasplen1 Apr 24, 2015 9:33 AM Flag

    panda, thanks for the additional info. From Michael's calculations, based on the latest presentation in April, the deduction was that Avanafil product revenue will come in between 12-13MM. That is despite the M&A disruption you mentioned. The non-US countries may have more than made up for any temporary loss in the US scripts. Of course, I don't know how the weakening Euro (vs USD) plays into all of this.

  • betasplen1 betasplen1 Apr 23, 2015 3:17 PM Flag

    OK, I looked at rt1's earlier response to this topic. Scratch that $15MM off the list. So, total will be 12.5MM (Avanafil product revenue) +11.5MM (EU milestone) +2MM (royalties) +15MM (Qsymia) = $41MM. Will be a big beat of current estimates but not enough to turn a profit yet. Maybe by 3Q15 at the current rate of revenue growth and expense reductions...

6.30+0.04(+0.64%)May 29 4:00 PMEDT